Reducing Problematic Substance Use in Youth With Chronic Medical Conditions

Alcohol Abuse Clinical Trial

Official title:

Reducing Problematic Substance Use in Youth With Chronic Medical Conditions

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT01709201
• Other study ID #: FP01009751
• Status: Withdrawn
• Phase: N/A
• First received: October 15, 2012
• Last updated: June 19, 2017
• Start date: July 2013
• Est. completion date: June 2015

Study information

• Verified date: June 2017
• Source: Boston Children’s Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators goal is to pilot a substance use-related brief intervention (BI) for youth with chronic medical conditions, obtaining preliminary evidence of feasibility, acceptability and impacts of the approach for reducing substance use among this group.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: June 2015
• Est. primary completion date: December 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 14 Years to 18 Years

Eligibility

Inclusion Criteria:

• 14-18 years old

• Currently being treated for diabetes, rheumatologic disorders, asthma, or ulcerative colitis (UC) at Boston Children's Hospital with a duration of chronic illness of at least one year

• Previous participation in the screening validation study

• Evidence of problems related to substance use

Exclusion Criteria:

• Medically or emotionally unstable or otherwise unable to provide assent/consent

• Unable to speak/read English

• Unable to use a computer keyboard and/or complete an interviewer-assisted questionnaire

Related Conditions & MeSH terms

• Alcohol Abuse
• Alcoholism
• Drug Abuse
• Substance-Related Disorders

Intervention

Behavioral:
• Brief Intervention
Those in the intervention arm will undergo a 10-minute discussion with a trained interventionist aimed at encouraging decreased substance use.

Locations

Country	Name	City	State
United States	Boston Children's Hospital	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Boston Children’s Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Percent Days Abstinent 90 days post baseline	We will compare the percent days abstinent from substances between the Treatment as Usual and Intervention groups 90 days post baseline	90 days post baseline
Other	Medical complications 90 days post baseline	We will evaluate the incidents of disease complications between the Treatment as Usual and Intervention groups 30 days post baseline	90 days post baseline
Primary	Percent days abstinent	We will compare the percent days abstinent from substances between the Treatment as Usual and Intervention groups 30 days post baseline	30 days post baseline
Secondary	Medical complications	We will evaluate the incidents of disease complications between the Treatment as Usual and Intervention groups 30 days post baseline	30 days post baseline